# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: James Madison (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN007-SYN
- Date: 2026-04-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Josiah Pembroke-Achebe, MD
- Calendar frame: modern shifted

## What we are working on

- For two years he has had sudden spells in which his mind seems to stop; he is afraid of having one in public or at the wheel **S**
- He feels low and worried, and does not expect to live long **S**
- He wants to know whether he has epilepsy and whether he can study law and take part in public life **S**

## Your goals

- Cause of the episodes established by the second visit. Target: 2026-04-30. Recorded outcome: Functional/dissociative seizures documented by video-EEG; epilepsy and syncope excluded. **S**
- Antiseizure medicine stopped safely. Target: 2026-06-11. Recorded outcome: Levetiracetam tapered over three weeks and stopped, with no change in events and less irritability. **S**
- Events reduced by at least half, then free of events for three months. Target: 2026-12-31. Recorded outcome: From two or three a month to one in the last two months; none for five weeks. **S**
- Depression and anxiety improved by at least 50 percent (PHQ-9 and GAD-7). Target: 2026-12-31. Recorded outcome: PHQ-9 13 to 6 and GAD-7 14 to 7. **S**
- No suicidal thoughts. Target: 2026-12-31. Recorded outcome: None at any visit. **S**

## What we agreed to do

- Diagnostic workup: a detailed history including a witness account or phone video if available, ECG, blood count, metabolic panel, TSH, brain MRI with an epilepsy protocol, and inpatient video-EEG monitoring to capture his habitual events; levetiracetam continued unchanged until the evaluation is complete. Guideline: LaFrance WC Jr, et al. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54(11):2005-2018 (PMID 24111933) (2013); Hingray C, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia 2025;66(11):4162-4182 (PMID 40884444) (2025); Fisher RS, et al. Operational classification of seizure types by the International League Against Epilepsy. Epilepsia 2017;58(4):522-530 (PMID 28276060) (2017); Fisher RS, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;55(4):475-482 (PMID 24730690) (2014) **S**
- Safety now: no driving until the evaluation is complete and the neurologist advises; showers rather than baths, no swimming alone or working at heights; seizure first aid for the people he lives and works near. Guideline: Tolchin B, et al. Seizures, Driver Licensure, and Medical Reporting Update: An AAN Position Statement. Neurology 2025;104(7):e213459 (PMID 40073306) (2025); First Aid for Seizures (2026) **S**
- Suicide risk assessment with a written safety plan: warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; the rifle locked with the ammunition stored separately; safety reviewed at every visit. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Neurology consultation (epilepsy and functional neurological disorder) with admission for video-EEG monitoring, on the diagnosis, the antiseizure medicine, and treatment. Guideline: LaFrance WC Jr, et al. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54(11):2005-2018 (PMID 24111933) (2013); Hingray C, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia 2025;66(11):4162-4182 (PMID 40884444) (2025); Fisher RS, et al. Operational classification of seizure types by the International League Against Epilepsy. Epilepsia 2017;58(4):522-530 (PMID 28276060) (2017) **S**
- Explaining the diagnosis: functional/dissociative seizures named and explained in person and in writing as real, common, and not epilepsy or feigning; how the brain can switch off awareness under strain; why antiseizure medicines do not help; that treatment works; a reliable written and online resource; a follow-up appointment to answer questions. Guideline: Hingray C, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia 2025;66(11):4162-4182 (PMID 40884444) (2025); Hall-Patch L, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia 2010;51(1):70-78 (PMID 19453708) (2010); Stone J, et al. Explanation as treatment for functional neurologic disorders. Handb Clin Neurol 2016;139:543-553 (PMID 27719870) (2016) **S**
- Levetiracetam withdrawn: 250 mg twice daily for two weeks, 250 mg at night for one week, then stopped; no driving during the taper. Guideline: LaFrance WC Jr, et al. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54(11):2005-2018 (PMID 24111933) (2013); Hingray C, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia 2025;66(11):4162-4182 (PMID 40884444) (2025); Fisher RS, et al. Operational classification of seizure types by the International League Against Epilepsy. Epilepsia 2017;58(4):522-530 (PMID 28276060) (2017); Tolchin B, et al. Seizures, Driver Licensure, and Medical Reporting Update: An AAN Position Statement. Neurology 2025;104(7):e213459 (PMID 40073306) (2025) **S**
- CBT-informed psychotherapy for functional seizures: twelve weekly sessions with a psychologist experienced in functional neurological disorder, with an event diary, recognition of warning sensations, grounding techniques, work on avoidance, sleep, and worry, and a relapse-prevention plan. Guideline: LaFrance WC Jr, et al. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54(11):2005-2018 (PMID 24111933) (2013); Hingray C, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia 2025;66(11):4162-4182 (PMID 40884444) (2025); Fisher RS, et al. Operational classification of seizure types by the International League Against Epilepsy. Epilepsia 2017;58(4):522-530 (PMID 28276060) (2017); LaFrance WC Jr, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 2014;71(9):997-1005 (PMID 24989152) (2014); Goldstein LH, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry 2020;7(6):491-505 (PMID 32445688) (2020) **S**
- Measurement-based care for depression and anxiety: PHQ-9 and GAD-7 at least monthly during treatment; psychotherapy, an SSRI such as sertraline, or both, by shared decision once the cause of the events is clear. Guideline: CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022) **S**
- Studies and daily life: a regular sleep window of at least seven hours, study blocks with breaks, academic accommodations for testing (extra breaks), and a return to civic meetings with a friend who knows the first-aid plan. Guideline: LaFrance WC Jr, et al. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54(11):2005-2018 (PMID 24111933) (2013); Hingray C, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia 2025;66(11):4162-4182 (PMID 40884444) (2025); Fisher RS, et al. Operational classification of seizure types by the International League Against Epilepsy. Epilepsia 2017;58(4):522-530 (PMID 28276060) (2017); LaFrance WC Jr, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 2014;71(9):997-1005 (PMID 24989152) (2014); Goldstein LH, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry 2020;7(6):491-505 (PMID 32445688) (2020) **S**
- Driving: may resume once free of events for at least three months and with the neurologist's agreement, following state licensing rules and the AAN 2025 position. Guideline: Tolchin B, et al. Seizures, Driver Licensure, and Medical Reporting Update: An AAN Position Statement. Neurology 2025;104(7):e213459 (PMID 40073306) (2025) **S**

## Follow-up

- 2026-04-07: Primary care visit for two years of recurrent sudden episodes of unresponsiveness, with low mood and anxiety, on levetiracetam started without a diagnosis **S**
- 2026-04-30: Discharge-day review after video-EEG monitoring: diagnosis, its explanation, and the epilepsy and functional neurological disorder consultation **S**
- 2026-06-11: Six-week review after the diagnosis: levetiracetam withdrawn, psychotherapy under way, mood and anxiety **S**
- 2026-07-16: Preventive health visit at 23 **S**
- 2026-09-24: Three-month review after completing psychotherapy: events, mood, driving, and his studies **S**

This teaching document does not replace care from a qualified clinician.
